{
    "elements": [
        {
            "type": "image",
            "sequence_num": 1,
            "data": {
                "url": "18028 Anticipatory Prescribing for 'Just in Case' Medication 1.0.001.png"
            }
        },
        {
            "type": "table",
            "sequence_num": 2,
            "data": {
                "num_rows": 15,
                "num_cols": 3,
                "table_items": [
                    {
                        "text": "Document Title:"
                    },
                    {
                        "text": "ANTICIPATORY PRESCRIBING OF \u2018JUST IN CASE' MEDICATION FOR SYMPTOM CONTROL"
                    },
                    {
                        "text": "Document Reference/Register no:"
                    },
                    {
                        "text": "18028"
                    },
                    {
                        "text": "Version Number:"
                    },
                    {
                        "text": "1.0"
                    },
                    {
                        "text": "Document type: (Policy/ Guideline/ SOP)"
                    },
                    {
                        "text": "Guideline"
                    },
                    {
                        "text": "To be followed by: (Target Staff)"
                    },
                    {
                        "text": "All Clinical Staff"
                    },
                    {
                        "text": "Ratification Issue Date: (Date document is uploaded onto the intranet)"
                    },
                    {
                        "text": "th17 December 2018"
                    },
                    {
                        "text": "Review Date:"
                    },
                    {
                        "text": "th16 December 2021"
                    },
                    {
                        "text": "Developed in response to:"
                    },
                    {
                        "text": "Department of Health. End of life care strategy 2008 Care Quality Commission 2010"
                    },
                    {
                        "text": "Contributes to HSC Act 2008 (Regulated Activities) Regulations 2014(Part 3); and CQC Regulations 2009 (Part 4) CQC Fundamental Standards of Quality and Safety:"
                    },
                    {
                        "text": "10,11,12"
                    },
                    {
                        "text": "Issuing Division/Directorate:"
                    },
                    {
                        "text": "Clinical Support Services"
                    },
                    {
                        "text": "Author/Contact: (Asset Administrator)"
                    },
                    {
                        "text": "Charlotte Hoctor (End of Life Care Facilitator) Farleigh Hospice Mid Essex Commissioning Group Provide"
                    },
                    {
                        "text": "Hospital Sites: (tick appropriate box/es to indicate status of policy review i.e. joint/ independent)"
                    },
                    {
                        "text": "\uf0fcMEHT \u25a1 BTUH \u25a1 SUH"
                    },
                    {
                        "text": "Consultation:"
                    },
                    {
                        "text": "(Refer to page 2)"
                    },
                    {
                        "text": "Approval Group / Committee(s):"
                    },
                    {
                        "text": "n/a"
                    },
                    {
                        "text": "Date:"
                    },
                    {
                        "text": "n/a"
                    },
                    {
                        "text": "Professionally Approved by: (Asset Owner)"
                    },
                    {
                        "text": "Daniel Spooner (Deputy Director of Nursing)"
                    },
                    {
                        "text": "Date:"
                    },
                    {
                        "text": "4th October 2018"
                    },
                    {
                        "text": "Ratification Group(s):"
                    },
                    {
                        "text": "Document Ratification Group Chairman's Action"
                    },
                    {
                        "text": "Date:"
                    },
                    {
                        "text": "3rd December 2018"
                    },
                    {
                        "text": "Executive and Clinical Directors (Communication of minutes from Document Ratification Group"
                    },
                    {
                        "text": "Date: December 2018"
                    },
                    {
                        "text": "Distribution Method:"
                    },
                    {
                        "text": "Trust Intranet/ Internet"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    }
                ]
            }
        },
        {
            "type": "image",
            "sequence_num": 3,
            "data": {
                "url": "18028 Anticipatory Prescribing for 'Just in Case' Medication 1.0.002.png"
            }
        },
        {
            "type": "table",
            "sequence_num": 4,
            "data": {
                "num_rows": 13,
                "num_cols": 2,
                "table_items": [
                    {
                        "text": "Consulted With:"
                    },
                    {
                        "text": "Post/ Approval Committee/ Group:"
                    },
                    {
                        "text": "Date:"
                    },
                    {
                        "text": "Dr Claire Plunkett"
                    },
                    {
                        "text": "Consultant in Palliative Medicine"
                    },
                    {
                        "text": "July 2018"
                    },
                    {
                        "text": "Dr Srirupa Gupta"
                    },
                    {
                        "text": "Consultant in Palliative Medicine"
                    },
                    {
                        "text": "Dr Peddasomayajula Subrahmanyam"
                    },
                    {
                        "text": "Chair Medicines Optimisation & Safety Group"
                    },
                    {
                        "text": "4th October 2018"
                    },
                    {
                        "text": "Alison Felton"
                    },
                    {
                        "text": "Chief Pharmacist"
                    },
                    {
                        "text": "Rajesh Jethwa"
                    },
                    {
                        "text": "Pharmacist"
                    },
                    {
                        "text": "Maria Richards"
                    },
                    {
                        "text": "Pharmacist"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    }
                ]
            }
        },
        {
            "type": "table",
            "sequence_num": 5,
            "data": {
                "num_rows": 1,
                "num_cols": 2,
                "table_items": [
                    {
                        "text": "Related Trust Policies (to be read in conjunction with)"
                    },
                    {
                        "text": "Policy: 08083 Controlled Drugs Policy Policy: 08084 Prescribing of Medicines for Inpatients Policy: 08103 Administration of Medicines for Inpatients Palliative Care Formulary 6th edition"
                    }
                ]
            }
        },
        {
            "type": "table",
            "sequence_num": 6,
            "data": {
                "num_rows": 14,
                "num_cols": 3,
                "table_items": [
                    {
                        "text": "Document Review History:"
                    },
                    {
                        "text": "Version No:"
                    },
                    {
                        "text": "Authored/Reviewer:"
                    },
                    {
                        "text": "Summary of amendments/ Record documents superseded by:"
                    },
                    {
                        "text": "Issue Date:"
                    },
                    {
                        "text": "1.0"
                    },
                    {
                        "text": "Charlotte Hoctor"
                    },
                    {
                        "text": "Newly created"
                    },
                    {
                        "text": "17th December 2018"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    }
                ]
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 7,
            "data": {
                "is_heading": 1,
                "text": "INDEX"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 8,
            "data": {
                "is_heading": 0,
                "text": "Appendix 1 - List of palliative care pharmacies in Mid Essex"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 9,
            "data": {
                "is_heading": 0,
                "text": "Appendix 2 \u2013 Equality Impact Assessment Form"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 10,
            "data": {
                "is_heading": 1,
                "prefix": 1.0,
                "text": "Purpose"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 11,
            "data": {
                "is_heading": 0,
                "prefix": 1.1,
                "text": "Farleigh Hospice, Mid Essex Hospital Services NHS Trust, Provide and Mid Essex Clinical Commissioning Group (CCG) have developed this clinical guidelines to provide a safe and consistent framework for the use of just in case (JiC) medications for patients who are in the last weeks of life."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 12,
            "data": {
                "is_heading": 0,
                "prefix": 1.2,
                "text": "To ensure that:"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 13,
            "data": {
                "is_heading": 0,
                "text": "Common symptoms in the last weeks of life (e.g. pain, excess secretions, nausea and vomiting, agitation and breathlessness) are anticipated and treated promptly. Prescribing for those at risk of sudden deterioration, such as in haemorrhage or choking may also be indicated and medication will be prescribed accordingly."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 14,
            "data": {
                "is_heading": 0,
                "text": "Appropriate JiC medicines are prescribed in advance for the patient and stored in the patient's home."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 15,
            "data": {
                "is_heading": 0,
                "text": "The JiC medicines can be easily identified in the home by healthcare professionals by ensuring they are appropriately labelled."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 16,
            "data": {
                "is_heading": 0,
                "text": "Patients and carers understand the purpose of the JiC medication."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 17,
            "data": {
                "is_heading": 1,
                "prefix": 2.0,
                "text": "Introduction"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 18,
            "data": {
                "is_heading": 0,
                "prefix": 2.1,
                "text": "Patients with a life limiting illness, who are deteriorating often experience new or worsening symptoms as they approach the last days of life and may be unable to swallow oral medication. This guidance seeks to avoid distress caused by delayed access to medicines by anticipating need, and providing anticipatory or \u2018just in case' medication in the home, for the management of symptoms which commonly occur in the last days of life."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 19,
            "data": {
                "is_heading": 0,
                "prefix": 2.2,
                "text": "Patients who deteriorate or develop uncontrolled symptoms will always require a full clinical assessment to ensure there is appropriate treatment of any reversible factors and a clear management plan. Anticipatory prescribing should be tailored to the individual patient and circumstances taking into account the risks and benefits of prescribing in advance. Patients and carers must consent to storing JiC medications in the home."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 20,
            "data": {
                "is_heading": 1,
                "prefix": 3.0,
                "text": "Scope"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 21,
            "data": {
                "is_heading": 0,
                "prefix": 3.1,
                "text": "This guidance covers anticipatory prescribing for symptoms in the last weeks of life. It does not include guidance on the diagnosis of dying patients or guidance on other aspects of care at the end of life."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 22,
            "data": {
                "is_heading": 0,
                "prefix": 3.2,
                "text": "It is relevant to:"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 23,
            "data": {
                "is_heading": 0,
                "text": "Patients in the community with a life limiting illness who have been assessed by a qualified healthcare professional as actively deteriorating and are in the last few weeks or days of life."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 24,
            "data": {
                "is_heading": 0,
                "text": "Healthcare professionals in the community and in-patient settings caring for these patients e.g."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 25,
            "data": {
                "is_heading": 0,
                "prefix": 3.3,
                "text": "This guidance will refer to any registered nurse with the appropriate competencies who may take the lead, or be involved in the provision, or administration of JiC medication (e.g. Hospice at Home, community nurses)."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 26,
            "data": {
                "is_heading": 0,
                "prefix": 3.4,
                "text": "Ambulance clinicians with the necessary competencies (defined by their own policy) may administer as required (PRN) medications recorded on an authorisation chart but are not trained in the use of syringe pumps."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 27,
            "data": {
                "is_heading": 0,
                "prefix": 3.5,
                "text": "The principles of anticipatory prescribing apply to patients in care homes and nursing homes. See cautions below with regards to authorising syringe pumps in advance or with dose ranges in a nursing home setting."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 28,
            "data": {
                "is_heading": 0,
                "prefix": 3.6,
                "text": "This guidance recommends there is a consistency of approach in prescribing by the use of the community drug chart."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 29,
            "data": {
                "is_heading": 0,
                "text": "."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 30,
            "data": {
                "is_heading": 1,
                "prefix": 4.0,
                "text": "Definitions"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 31,
            "data": {
                "is_heading": 0,
                "text": "Provision of medication in advance in anticipation of symptoms occurring in the last few weeks of life has been termed anticipatory prescribing or pre-emptive prescribing. The terms \u2018Just in Case' (JiC) medication, anticipatory medication and \u2018Just in Case' box are also used. For the purpose of this guideline the terms \u2018Just in Case' (JiC) medication and anticipatory prescribing will be used."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 32,
            "data": {
                "is_heading": 1,
                "prefix": 5.0,
                "text": "Responsibilities"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 33,
            "data": {
                "is_heading": 0,
                "text": "A summary of the roles listed in the procedure and the responsibilities are detailed in the guidance."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 34,
            "data": {
                "is_heading": 1,
                "prefix": 6.0,
                "text": "Specific Procedure"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 35,
            "data": {
                "is_heading": 0,
                "prefix": 6.1,
                "text": "The patient will have been assessed by a qualified healthcare professional as actively deteriorating and in the last few weeks or days of life. This will have been communicated to the patient and, their relatives/carers wherever possible as well as all healthcare professionals involved in the patient's care."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 36,
            "data": {
                "is_heading": 0,
                "prefix": 6.2,
                "text": "The patient and, wherever possible, their relative/carer must understand the purpose of the JiC/syringe pump medication. They will need to agree to the principle of anticipatory prescribing for end of life symptoms, and consent for use. For patients who lack capacity the principles of the Mental Capacity Act regarding treatment decisions must be followed and best interest decisions must be made with the patients family/ representative e.g. Lasting Power of Attorney (LPA) and be recorded on a Mental Capacity Assessment form. If the patient does not have family or a representative who can act on their behalf, the case must be referred to an Independent Mental Capacity Advocate (IMCA). Referral to an IMCA should not delay the prescription and administration of medication. Written information should be provided to the patient and their relatives /carers."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 37,
            "data": {
                "is_heading": 0,
                "prefix": 6.3,
                "text": "If there is uncertainty as to whether the patient is in the last few weeks or days of life, anticipatory prescribing should be considered only for those who have actively engaged in advance care planning discussions, favour a palliative approach to the management of their illness and have expressed the wish to avoid hospital admissions and remain at home."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 38,
            "data": {
                "is_heading": 0,
                "prefix": 6.4,
                "text": "CAUTIONS:"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 39,
            "data": {
                "is_heading": 0,
                "text": "6.4.1 In cases where there is a history or suspicion of drug misuse amongst carers or visitors  to  the  house  an  individual  risk  assessment  will  be  needed  prior  to  the prescription of JiC medications"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 40,
            "data": {
                "is_heading": 0,
                "text": "6.4.2 Similarly, in cases where significant family distress is highlighted as a potential risk to the patient (e.g. through deliberate administration of medications with the aim of hastening death) a risk assessment should be undertaken and measures put in place to minimise this risk (e.g. locked box for JiC medication storage)."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 41,
            "data": {
                "is_heading": 1,
                "prefix": 7.0,
                "text": "Procedure for Provision of \u2018Just in Case' Medication"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 42,
            "data": {
                "is_heading": 0,
                "prefix": 7.1,
                "text": "Doctor, GPs, Specialist Palliative Care (SPC) Community Nurse Specialists (CNS)/community registered nurses or other relevant healthcare professional should identify appropriate patients ahead of need. The need for JiC medication should be part of the regular review of patients during the Gold Standards Framework (GSF)/Enhanced multidisciplinary team meetings (MDT), specialist palliative care MDT's and hospital ward rounds."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 43,
            "data": {
                "is_heading": 0,
                "prefix": 7.2,
                "text": "It is important to discuss the need for JiC medication with both the patient and their relative/carer wherever possible and the healthcare professionals involved in their care. Discussions should include:"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 44,
            "data": {
                "is_heading": 0,
                "text": "Current medical situation and the plan for care."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 45,
            "data": {
                "is_heading": 0,
                "text": "Concept of JiC medication"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 46,
            "data": {
                "is_heading": 0,
                "text": "Consent for medications to be left in the home"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 47,
            "data": {
                "is_heading": 0,
                "prefix": 7.3,
                "text": "A doctor, GP, or non-medical prescriber (with appropriate training) who is actively involved with the patient should provide an individualised prescription taking into account the patients current medication, current and past medical history and known intolerance or allergies to medication. The prescriber should refer to relevant guidelines under section 6. A separate prescription (FP10) is required for each drug prescribed."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 48,
            "data": {
                "is_heading": 0,
                "prefix": 7.4,
                "text": "The prescriber should authorise the same drugs on the community drug chart at the time of prescribing the JiC medication, this should include the review date. The prescriber should record the prescribing of JiC medication and the review date in the patient's electronic record, discharge summary and advance care plan (ACP)."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 49,
            "data": {
                "is_heading": 0,
                "prefix": 7.5,
                "text": "The prescriber or other registered nurse working in the community will ensure the relative/carer is able to obtain the medication prescribed, or, if the patient is in hospital, relevant medications should be prescribed as TTAs (To Take Away Medications)."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 50,
            "data": {
                "is_heading": 0,
                "prefix": 7.6,
                "text": "If the medication is required urgently the prescriber should ensure the nominated local pharmacy has enough stock to dispense the prescription or refer the relative/carer to the list of pharmacies which stock palliative care medication (see Appendix 2)."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 51,
            "data": {
                "is_heading": 0,
                "prefix": 7.7,
                "text": "The prescriber should check the understanding of the patient and their relative/carer about the plan of care and the JiC medication and give them an information leaflet (Refer to Appendix 1)."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 52,
            "data": {
                "is_heading": 1,
                "prefix": 8.0,
                "text": "Availability of \u2018Just in Case' Medication Out of Hours"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 53,
            "data": {
                "is_heading": 0,
                "prefix": 8.1,
                "text": "The patient's usual community pharmacy should continue to be the first port of call and will remain the usual supplier for non-urgent prescriptions and ongoing patient management."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 54,
            "data": {
                "is_heading": 0,
                "prefix": 8.2,
                "text": "There is likely to be an established relationship between the usual pharmacy, the patient and the relatives/carers, and it is important to retain this where possible."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 55,
            "data": {
                "is_heading": 0,
                "prefix": 8.3,
                "text": "The palliative care drugs in community pharmacy service should only be used for urgent or immediate needs (e.g. out of hours or where a patient's condition changes rapidly)."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 56,
            "data": {
                "is_heading": 0,
                "prefix": 8.4,
                "text": "The pharmacy will stock a locally agreed range of specialist medicines and will make a commitment to ensure that users of this service have prompt access to these medicines at all times. The selected pharmacies will hold a stock of an agreed formulary of drugs. These drugs do not cover all eventualities but the pharmacy can usually order supplies of a prescribed drug to be available for the same day delivery, if ordered before 11.30am, and for the following morning if ordered before 5pm (Monday to Friday)."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 57,
            "data": {
                "is_heading": 0,
                "prefix": 8.5,
                "text": "Pharmacists must be provided with the original prescription, on an FP10 or FP10 (HP) for a controlled drug, a fax is not acceptable. Anyone collecting a prescription for a controlled drug whether a healthcare professional or the patient; or their carer should take some form of identification (ID) with them. The pharmacist is required to ask for ID and record whether they have seen it."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 58,
            "data": {
                "is_heading": 0,
                "prefix": 8.6,
                "text": "For urgent requests, those requesting the prescription should avoid ordering excess quantities so that supplies remain available for as many patients as possible. It is unlikely that a supply for more than three days will be required before normal supplies can be obtained from the patient's usual pharmacy."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 59,
            "data": {
                "is_heading": 0,
                "prefix": 8.7,
                "text": "If the pharmacist cannot fulfil the prescription within a timeframe that meets the patient's needs, they are responsible for telephoning another pharmacy to confirm that stock is available"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 60,
            "data": {
                "is_heading": 0,
                "prefix": 8.8,
                "text": "Prescribers are encouraged to include communication with the local community pharmacist as an important step when planning the medication needs of their patients."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 61,
            "data": {
                "is_heading": 1,
                "prefix": 9.0,
                "text": "Prescribing Guidance for JiC Medications"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 62,
            "data": {
                "is_heading": 0,
                "prefix": 9.1,
                "text": "Please note: When exercising their judgement, health professionals are expected to take this guidance fully into account alongside the individual needs, preferences and values of the patient."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 63,
            "data": {
                "is_heading": 0,
                "prefix": 9.2,
                "text": "The prescriber must consider the risks and benefits of prescribing in advance, particularly in a rapidly changing patient. The drugs and doses prescribed will need regular review. In particular, it will not always be appropriate to prescribe syringe pump medication in advance due to the difficulty of predicting what drugs and doses a patient may need."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 64,
            "data": {
                "is_heading": 1,
                "prefix": 10.0,
                "text": "Provision of as Required (PRN) Subcutaneous Medications only"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 65,
            "data": {
                "is_heading": 0,
                "prefix": 10.1,
                "text": "For patients who have been assessed by an experienced clinician(s) as deteriorating and thought to be in the last few weeks of life."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 66,
            "data": {
                "is_heading": 0,
                "prefix": 10.2,
                "text": "Prescribing should take place if it is felt that the patient may soon be unable to take/absorb medication via the enteral route, in patients with issues such as in nausea and vomiting, a fluctuating level of consciousness or an inability to swallow."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 67,
            "data": {
                "is_heading": 0,
                "prefix": 10.3,
                "text": "Consideration needs to be given to patients at risk of a sudden change to condition (i.e. those with seizure risk/bleeding risk)."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 68,
            "data": {
                "is_heading": 0,
                "prefix": 10.4,
                "text": "A doctor, GP or non-medical prescriber (with the necessary experience/within their scope of practice ) who is actively involved with the patient should provide an individualised prescription (FP10) for JiC medications, taking into account the patients current medication, current and past medical history, organ function and known intolerance or allergies to medication."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 69,
            "data": {
                "is_heading": 0,
                "prefix": 10.5,
                "text": "Current medication should be regularly re-assessed and unnecessary medications discontinued. Some drugs may be of benefit up until the time of death if the patient is still able to swallow."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 70,
            "data": {
                "is_heading": 0,
                "prefix": 5.0,
                "text": "For all patients prescribe subcutaneous medication for each of the  common symptoms in the last few weeks of life. These include:"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 71,
            "data": {
                "is_heading": 0,
                "text": "Pain"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 72,
            "data": {
                "is_heading": 0,
                "text": "Agitation and restlessness"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 73,
            "data": {
                "is_heading": 0,
                "text": "Nausea and vomiting"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 74,
            "data": {
                "is_heading": 0,
                "text": "Respiratory secretions"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 75,
            "data": {
                "is_heading": 0,
                "text": "Breathlessness"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 76,
            "data": {
                "is_heading": 0,
                "prefix": 10.8,
                "text": "The following medications are usually provided:"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 77,
            "data": {
                "is_heading": 0,
                "text": "Opioid: The appropriate drug and dose should be chosen for the individual. Morphine sulphate is the usual drug of choice for subcutaneous (SC) administration, unless the patient is already maintained on an alternative opioid or is in renal failure. Note the highest concentration of injectable morphine sulphate is 30mg/ml therefore a maximum PRN injection dose is 60mg (2mls). Diamorphine should be used for higher doses."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 78,
            "data": {
                "is_heading": 0,
                "text": "Antiemetic: The appropriate drug should be chosen for the individual. Tailor the anti-emetic choice based on the likely cause. Haloperidol is the preferred first line anti-emetic unless there is a history of Parkinson's disease or seizures"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 79,
            "data": {
                "is_heading": 0,
                "text": "Sedative: midazolam is the usual first line drug for restlessness/anxiety at the end of life. Haloperidol or levomepromazine should be used (instead of midazolam) for delirium/hallucinations."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 80,
            "data": {
                "is_heading": 0,
                "text": "Anticholinergic for secretions: hyoscine butylbromide is the first line anti- cholinergic."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 81,
            "data": {
                "is_heading": 1,
                "prefix": 11.0,
                "text": "Standard Example of Subcutaneous PRN Drugs to Supply only"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 82,
            "data": {
                "is_heading": 0,
                "text": "Analgesic: morphine, diamorphine (or oxycodone) at a dose of 1/6 of the total 24 hour opioid dose administered up to 1 hourly."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 83,
            "data": {
                "is_heading": 0,
                "text": "Antiemetic: cyclizine 50mg (maximum of 150mg/24 hours), haloperidol 0.5-1.5mg (maximum of 5mg/24 hours) levomepromazine 6.25-12.5mg (maximum of 25mg/24 hours)"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 84,
            "data": {
                "is_heading": 0,
                "text": "Anxiety without delirium: midazolam 2.5-5mg up to 1 hourly,"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 85,
            "data": {
                "is_heading": 0,
                "text": "Anxiety with delirium: haloperidol 0.5-1.5mg up to 8 hourly, levomepromazine"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 86,
            "data": {
                "is_heading": 0,
                "text": "12.5 -25mg 4 hourly"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 87,
            "data": {
                "is_heading": 0,
                "text": "Anti-secretory:Hyoscine butylbromide 20mg up to 120mg/24 hours, glycopyrronium 0.2mg up to 1.2mg/24 hours, Hyoscine hydrobromide 0.4mg sc up to 2.4mg/24 hours"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 88,
            "data": {
                "is_heading": 0,
                "prefix": 11.1,
                "text": "The anticipatory prescribing of 24 hour syringe pumps (or continuous subcutaneous infusions \u2013 CSCI's) is not best practice and therefore discouraged. If patients are requiring frequent administration of PRN medications, a reassessment by an appropriately trained healthcare professional should be undertaken to exclude any reversible causes for the increase in symptoms (e.g. urinary retention) and to determine the on-going medication needs of the patient. At this point, if deemed necessary, a CSCI may be commenced."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 89,
            "data": {
                "is_heading": 0,
                "prefix": 11.2,
                "text": "CAUTIONS:"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 90,
            "data": {
                "is_heading": 0,
                "text": "For patients with Parkinson's disease:"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 91,
            "data": {
                "is_heading": 0,
                "text": "Avoid use of anti-emetics such as haloperidol and metoclopramide. Subcutaneous cyclizine should be used first line or low dose levomepromazine may be used second line with caution."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 92,
            "data": {
                "is_heading": 0,
                "text": "For patients who have a Fentanyl patch for pain:"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 93,
            "data": {
                "is_heading": 0,
                "text": "The patch should be kept in place and changed as usual as stated on the patient's prescription. However if they are unable to swallow, they will require PRN subcutaneous analgesia prescribed at a dose appropriate to their patch dose."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 94,
            "data": {
                "is_heading": 1,
                "prefix": 12.0,
                "text": "Provision of Syringe Pump Medication for Subcutaneous Administration over 24 hours"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 95,
            "data": {
                "is_heading": 0,
                "text": "Syringe pumps are small battery operated pumps that allow continuous, subcutaneous drug infusions. This permits parenteral drug administration with minimal patient burden and has the advantage of steady plasma levels for a wide range of drugs available for symptom control. They are not just for use in the terminal phase but in any situation where the oral route is inappropriate or unreliable."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 96,
            "data": {
                "is_heading": 1,
                "prefix": 12.1,
                "text": "Benefits of use"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 97,
            "data": {
                "is_heading": 0,
                "text": "More control of dose administration, especially if gut absorption is suspect"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 98,
            "data": {
                "is_heading": 0,
                "text": "Certainty of drug absorption avoiding peaks and troughs in drug levels"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 99,
            "data": {
                "is_heading": 0,
                "text": "Constant blood level of medication administered"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 100,
            "data": {
                "is_heading": 0,
                "text": "Comfort - decreases need for repeated injections, if oral route is not available"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 101,
            "data": {
                "is_heading": 0,
                "text": "Mobility and independence can be maintained, as compared to intravenous administration"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 102,
            "data": {
                "is_heading": 0,
                "prefix": 12.2,
                "text": "Indications for Use"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 103,
            "data": {
                "is_heading": 0,
                "text": "Inability to swallow"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 104,
            "data": {
                "is_heading": 0,
                "text": "Persistent nausea and vomiting"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 105,
            "data": {
                "is_heading": 0,
                "text": "Malabsorption"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 106,
            "data": {
                "is_heading": 0,
                "text": "Intestinal obstruction"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 107,
            "data": {
                "is_heading": 0,
                "text": "Semi or unconscious"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 108,
            "data": {
                "is_heading": 0,
                "text": "Rectal route not appropriate"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 109,
            "data": {
                "is_heading": 1,
                "prefix": 12.3,
                "text": "CAUTIONS:"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 110,
            "data": {
                "is_heading": 0,
                "text": "Restless patient who may dislodge the cannula"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 111,
            "data": {
                "is_heading": 0,
                "text": "Lack of sites e.g. because of oedema"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 112,
            "data": {
                "is_heading": 0,
                "prefix": 12.4,
                "text": "At the stage the patient loses the ability to take drugs orally or other reasons above; the medications should be reviewed and parenteral medications tailored according to current symptoms at an appropriate dose."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 113,
            "data": {
                "is_heading": 1,
                "prefix": 13.0,
                "text": "Use of either Unlicensed or Licensed Drugs for Unlicensed Purposes"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 114,
            "data": {
                "is_heading": 0,
                "prefix": 13.1,
                "text": "In palliative care the treatment of many symptoms involves the use of drugs that:"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 115,
            "data": {
                "is_heading": 0,
                "text": "(a) Have no licence at all"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 116,
            "data": {
                "is_heading": 0,
                "text": "Or"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 117,
            "data": {
                "is_heading": 0,
                "text": "(b) Are used outside the terms of the licence e.g. doses, routes"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 118,
            "data": {
                "is_heading": 0,
                "prefix": 13.2,
                "text": "The licensing process for drugs regulates the activities of pharmaceutical companies, and NOT a doctor's prescribing choice."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 119,
            "data": {
                "is_heading": 0,
                "prefix": 13.3,
                "text": "Drugs, which have been prescribed outside the licence, can be dispensed by pharmacists and administered by nurses."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 120,
            "data": {
                "is_heading": 0,
                "prefix": 13.4,
                "text": "Drugs which are being recommended off label or for unlicensed indication remain the responsibility of the prescriber. However, ongoing monitoring and review should be undertaken by the prescriber."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 121,
            "data": {
                "is_heading": 1,
                "prefix": 14.0,
                "text": "Prescribing Outside the Licence"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 122,
            "data": {
                "is_heading": 0,
                "prefix": 14.1,
                "text": "The General Medical Council's Good Practice in Prescribing Medicines \u2013 Guidance for doctors states the following:"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 123,
            "data": {
                "is_heading": 0,
                "prefix": 14.2,
                "text": "The responsibility for the consequences of these actions lies with the doctor prescribing. Whenever a doctor prescribes a drug (whether licensed use/route or not) the doctor must balance the potential good and the potential harm which might ensue in light of published evidence."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 124,
            "data": {
                "is_heading": 0,
                "prefix": 14.3,
                "text": "All symptoms and treatments should be clearly recorded in the patient's notes. Other professionals including pharmacists, GP's and nurses should be made aware of the drugs that their patients have been prescribed and they should also be given information, so that they understand their use in palliative care."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 125,
            "data": {
                "is_heading": 0,
                "prefix": 14.4,
                "text": "Nurses who are registered as independent prescribers can prescribe licensed medicines outside their licence (i.e. \u201coff-label\u201d) if this is accepted practice as well as licensed medicines within their clinical competence. Nurse independent prescribers can also prescribe unlicensed medicines and controlled drugs."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 126,
            "data": {
                "is_heading": 0,
                "prefix": 14.5,
                "text": "Patients should have access to information on the use of unlicensed drugs."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 127,
            "data": {
                "is_heading": 1,
                "prefix": 15.0,
                "text": "Forms/Templates to be used"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 128,
            "data": {
                "is_heading": 0,
                "text": "Drug Administration Record for Community Nursing"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 129,
            "data": {
                "is_heading": 1,
                "prefix": 16.0,
                "text": "Equality Impact Assessment"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 130,
            "data": {
                "is_heading": 0,
                "prefix": 16.1,
                "text": "This policy has been the subject of an Equality Impact Assessment following the template used for all Trust policies. The result of the assessment demonstrates that no one as a consequence of this policy is placed at a disadvantage over others (Refer to Appendix 2)"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 131,
            "data": {
                "is_heading": 1,
                "prefix": 17.0,
                "text": "References"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 132,
            "data": {
                "is_heading": 1,
                "text": "External References"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 133,
            "data": {
                "is_heading": 0,
                "text": "Palliative Care Formulary 5: Twycross, Wilcock, Mortimer, Charlesworth & Howard 2014 - Fifth Edition"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 134,
            "data": {
                "is_heading": 0,
                "text": "General Medical Council: Good practice in prescribing medicines \u2013 guidance for doctors. September 2008"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 135,
            "data": {
                "is_heading": 0,
                "text": "A single competency framework for all prescribers \u2013 National Prescribing Centre (Provided by NICE) Reviewed May 201"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 136,
            "data": {
                "is_heading": 0,
                "text": "Care of dying adults in the last days of life - NICE Guidance. December 2015"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 137,
            "data": {
                "is_heading": 1,
                "text": "Internal References"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 138,
            "data": {
                "is_heading": 0,
                "text": "Policy: 08083 Controlled Drugs Policy"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 139,
            "data": {
                "is_heading": 0,
                "prefix": 6.0,
                "text": "Policy: 08084 Prescribing of Medicines for Inpatients Policy: 08103 Administration of Medicines for Inpatients Palliative Care Formulary th edition"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 140,
            "data": {
                "is_heading": 1,
                "text": "Appendix 1"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 141,
            "data": {
                "is_heading": 1,
                "text": "List of palliative care pharmacies in Mid Essex (*100 hour pharmacies)"
            }
        },
        {
            "type": "table",
            "sequence_num": 142,
            "data": {
                "num_rows": 9,
                "num_cols": 5,
                "table_items": [
                    {
                        "text": "Location"
                    },
                    {
                        "text": "Pharmacy name"
                    },
                    {
                        "text": "Address"
                    },
                    {
                        "text": "Telephone"
                    },
                    {
                        "text": "Opening Hours"
                    },
                    {
                        "text": "Chelmsford"
                    },
                    {
                        "text": "Boots the Chemist"
                    },
                    {
                        "text": "Chelmer Village Retail Park, Chelmsford, CM2 6XE"
                    },
                    {
                        "text": "01245 349986"
                    },
                    {
                        "text": "Mon-Sat 09.00-20.00 Sun 10.30-16.30"
                    },
                    {
                        "text": "Chelmsford"
                    },
                    {
                        "text": "Sainsburys (Lloyds pharmacy)"
                    },
                    {
                        "text": "Lloyds Pharmacy Inside Sainsburys, 2 White Hart Lane, Springfield , Chelmsford, Essex, CM2 5PH"
                    },
                    {
                        "text": "01245311817"
                    },
                    {
                        "text": "Mon- Fri: 7.00- 23.00 Sat: 7.00-22.00 Sun: 10.00-16.00"
                    },
                    {
                        "text": "Maldon"
                    },
                    {
                        "text": "*Blackwater Pharmacy"
                    },
                    {
                        "text": "Princes Road, Maldon, CM9 5GP"
                    },
                    {
                        "text": "01621855118"
                    },
                    {
                        "text": "Mon-Fri 7.00-22.00 Sun 10.00-20.00"
                    },
                    {
                        "text": "Braintree"
                    },
                    {
                        "text": "Tesco Pharmacy"
                    },
                    {
                        "text": "1 The Square, Notley Green, Braintree CM77 7WW"
                    },
                    {
                        "text": "01376 396847"
                    },
                    {
                        "text": "Mon-Sat; 08.00-20.00 Sun: 10.00-16.00"
                    },
                    {
                        "text": "Witham"
                    },
                    {
                        "text": "Boots the Chemist"
                    },
                    {
                        "text": "42 Newland Street, Witham, CM8 2AR"
                    },
                    {
                        "text": "01376 513613"
                    },
                    {
                        "text": "Mon-Fri 8.45-17.30; Sat 08.45-17.30 Sun: 10.00-16.00"
                    },
                    {
                        "text": "Halstead"
                    },
                    {
                        "text": "Boots Halstead"
                    },
                    {
                        "text": "69-71, High St, Halstead, Essex, CO9 2JD"
                    },
                    {
                        "text": "01787 472220"
                    },
                    {
                        "text": "Mon-Sat: 8.30-18.00 Sun: 10.00-16.00"
                    },
                    {
                        "text": "South Woodham"
                    },
                    {
                        "text": "Govanis Pharmacy"
                    },
                    {
                        "text": "14 Queen Elizabeth Square, South Woodham Ferrers, CM3 5DT"
                    },
                    {
                        "text": "01245 321910"
                    },
                    {
                        "text": "Mon-Fri 09.30-18.00; Sat 09.30-17.00; Sun 10.00-12 noon"
                    },
                    {
                        "text": "Burnham"
                    },
                    {
                        "text": "*Burnham Pharmacy"
                    },
                    {
                        "text": "20-22 Station Road, Burnham-on-Crouch, CM0 8BQ"
                    },
                    {
                        "text": "01621 784660"
                    },
                    {
                        "text": "Mon-Sat: 07.00-22.30; Sun: 10.00-17.00"
                    }
                ]
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 143,
            "data": {
                "is_heading": 1,
                "text": "Anticipatory Prescribing of \u2018Just In Case' Medication for Symptom Control/ 18028 /1.0"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 144,
            "data": {
                "is_heading": 0,
                "prefix": 1.0,
                "text": ""
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 145,
            "data": {
                "is_heading": 1,
                "text": "Anticipatory Prescribing of \u2018Just In Case' Medication for Symptom Control/ 18028 /1.0"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 146,
            "data": {
                "is_heading": 1,
                "text": "Appendix 2: Preliminary Equality Analysis"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 147,
            "data": {
                "is_heading": 1,
                "text": "This assessment relates to: 18028 Anticipatory Prescribing for 'Just in Case' Medication"
            }
        },
        {
            "type": "table",
            "sequence_num": 148,
            "data": {
                "num_rows": 9,
                "num_cols": 3,
                "table_items": [
                    {
                        "text": "A change in a service to patients"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "A change to an existing policy"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "A change to the way staff work"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "A new policy"
                    },
                    {
                        "text": "X"
                    },
                    {
                        "text": "Something else (please give details)"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "Questions"
                    },
                    {
                        "text": "Answers"
                    },
                    {
                        "text": "What are you proposing to change?"
                    },
                    {
                        "text": "Introducing a new policy to formalise existing arrangement with the management of anticipatory prescribing at the end of life"
                    },
                    {
                        "text": "Why are you making this change? (What will the change achieve?)"
                    },
                    {
                        "text": "To ensure standardisation across mid-Essex whilst ensuring timely anticipatory prescribing that encompasses medication for the key symptoms at the end of life. This is in line with NICE QS144 where prescribing medicines in anticipation can avoid a lapse in symptom control, which could otherwise cause distress for the person who is dying and those close to them."
                    },
                    {
                        "text": "Who benefits from this change and how?"
                    },
                    {
                        "text": "Patients will benefit with medication for end of life symptoms being readily available when discharged to their preferred place of care"
                    },
                    {
                        "text": "Is anyone likely to suffer any negative impact as a result of this change? If no, please record reasons here and sign and date this assessment. If yes, please complete a full EIA."
                    },
                    {
                        "text": "No negative impact will result in this change"
                    },
                    {
                        "text": "a) Will you be undertaking any consultation as part of this change? b) If so, with whom?"
                    },
                    {
                        "text": "Yes Refer to pages 1 & 2"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    }
                ]
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 149,
            "data": {
                "is_heading": 1,
                "text": "Preliminary analysis completed by:"
            }
        },
        {
            "type": "table",
            "sequence_num": 150,
            "data": {
                "num_rows": 1,
                "num_cols": 6,
                "table_items": [
                    {
                        "text": "Name"
                    },
                    {
                        "text": "Charlotte Hoctor"
                    },
                    {
                        "text": "Job Title"
                    },
                    {
                        "text": "Facilitator End of Life Care"
                    },
                    {
                        "text": "Date"
                    },
                    {
                        "text": "12/11/2018"
                    }
                ]
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 151,
            "data": {
                "is_heading": 0,
                "prefix": 14.0,
                "text": ""
            }
        }
    ]
}